Table 2.
Medication in the Whole Sample and According to 30-Day In-Hospital Mortality
| Medications, % (n) | Whole Sample |
Survivors |
Nonsurvivors |
P∗ |
|---|---|---|---|---|
| n = 201 | n = 135 | n = 66 | ||
| Renin-angiotensin system inhibitors | ||||
| ARB or ACEI | 31.3 (63) | 36.3 (49) | 21.2 (14) | .03 |
| Renin-angiotensin system inhibitors† | ||||
| No ARB or ACEI | 68.7 (138) | 63.7 (86) | 78.8 (52) | Ref |
| ACEI | 18.9 (38) | 20.7 (28) | 15.2 (10) | .23 |
| ARB | 12.4 (25) | 15.6 (21) | 6.06 (4) | .05 |
| Calcium channel blockers | 16.4 (33) | 18.5 (25) | 12.1 (8) | .21 |
| Diuretics | 27.6 (55) | 26.1 (35) | 30.8 (20) | .46 |
| Beta-blockers | 43.5 (87) | 42.5 (57) | 45.5 (30) | .72 |
| Anticoagulants | 25.5 (51) | 24.6 (33) | 27.3 (18) | .55 |
| Antiplatelets | 25.0 (50) | 24.6 (33) | 25.8 (17) | .94 |
| PPI | 41.0 (82) | 41.8 (56) | 39.4 (26) | .79 |
| Antidepressants | 54.0 (108) | 56.7 (76) | 48.5 (32) | .22 |
| Neuroleptics | 23.5 (47) | 21.6 (29) | 27.3 (18) | .49 |
| Benzodiazepines | 55.0 (110) | 53.7 (72) | 57.6 (38) | .63 |
ARB, angiotensin II receptor blocker; ACEI, angiotensin-converting-enzyme inhibitors; PPI, proton-pump inhibitor.
∗
P values from univariate Cox regression model.
†
Overall difference between no ACEI or ARB, ACEI, ARB in Cox regression model, P = .06.